tirzepatide injection precio Mounjaro 2.5 mg / 0.5 ml Vial - Mounjaro (Tirzepatide) Injection 5 mg/0.5
Description
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): A multicentre, randomised, open-label, parallel-group, phase 3 trial
Niazi, Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025)
However, if higher doses are needed to compensate for lower bioavailability, the per-milligram cost advantage can shrink or disappear entirely
The solution should always be transparent with no cloudiness or particles
